14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

$22.79 (3.36%)

Volume: 1.941M

Closed: May 20, 2022

Hollow Logo Score: 3.852

ChemoCentryx Stock Forecast

BUY SELL NASDAQ:CCXI
$22.79 (3.36%)

Volume: 1.941M

Closed: May 20, 2022

Score Hollow Logo 3.852

ChemoCentryx Stock Price (Quote) NASDAQ:CCXI

$22.79 ( 3.36% ) Friday, 20th May 2022

Range Low Price High Price Comment
30 days $14.95 $23.28 Friday, 20th May 2022 CCXI stock ended at $22.79. This is 3.36% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 7.73% from a day low at $21.61 to a day high of $23.28.
90 days $14.95 $31.46
52 weeks $9.53 $42.16

Historical ChemoCentryx prices

Date Open High Low Close Volume
2022-05-20 $22.12 $23.28 $21.61 $22.79 1 941 201
2022-05-19 $20.79 $22.90 $20.79 $22.05 2 214 081
2022-05-18 $20.00 $21.44 $19.83 $20.86 1 499 189
2022-05-17 $19.66 $21.01 $19.44 $20.91 1 329 427
2022-05-16 $19.14 $20.37 $18.75 $19.20 1 178 727
2022-05-13 $17.82 $19.18 $17.62 $19.17 1 341 547
2022-05-12 $16.21 $17.63 $16.16 $17.35 1 362 769
2022-05-11 $17.83 $18.69 $16.49 $16.49 2 207 322
2022-05-10 $16.16 $18.12 $15.31 $17.89 3 332 105
2022-05-09 $16.81 $17.03 $14.95 $15.36 2 702 153
2022-05-06 $18.26 $19.48 $17.19 $17.38 8 446 652
2022-05-05 $16.67 $16.89 $15.28 $15.64 1 984 488
2022-05-04 $17.82 $17.82 $16.16 $16.99 2 592 886
2022-05-03 $18.70 $18.96 $17.51 $17.68 1 447 237
2022-05-02 $18.55 $19.05 $17.76 $18.77 1 694 682
2022-04-29 $18.90 $19.40 $18.36 $18.46 1 151 609
2022-04-28 $19.41 $19.41 $17.90 $19.04 903 423
2022-04-27 $19.25 $19.76 $18.82 $19.07 815 782
2022-04-26 $19.70 $19.76 $19.12 $19.19 1 446 174
2022-04-25 $19.10 $20.03 $19.01 $19.84 823 840
2022-04-22 $21.11 $21.37 $19.34 $19.49 490 470
2022-04-21 $21.11 $21.40 $19.53 $19.69 1 050 300
2022-04-20 $21.21 $21.71 $20.75 $20.88 1 089 300
2022-04-19 $20.80 $21.87 $20.53 $21.20 1 316 500
2022-04-18 $21.43 $21.43 $20.39 $20.69 1 174 400
2022-04-14 $22.10 $22.20 $21.17 $21.55 934 430
2022-04-13 $22.13 $22.41 $21.16 $22.15 1 353 721
2022-04-12 $22.25 $22.50 $20.69 $21.16 1 543 637
2022-04-11 $22.70 $22.90 $21.79 $21.94 756 542
2022-04-08 $23.71 $23.92 $22.75 $22.91 891 800
2022-04-07 $24.17 $24.78 $23.36 $23.81 1 494 200
2022-04-06 $24.39 $24.78 $23.86 $24.20 3 054 000
2022-04-05 $26.25 $26.29 $24.70 $24.74 755 300
2022-04-04 $26.86 $27.03 $25.64 $26.27 1 358 300
2022-04-01 $25.32 $26.77 $25.02 $26.71 876 542
2022-03-31 $25.13 $25.60 $24.89 $25.07 477 186
2022-03-30 $25.62 $26.43 $24.83 $25.01 516 692
2022-03-29 $24.51 $25.87 $24.34 $25.71 1 016 600
2022-03-28 $24.14 $24.68 $23.55 $24.33 549 800
2022-03-25 $24.30 $24.30 $23.28 $23.96 630 200
2022-03-24 $23.97 $24.65 $23.54 $24.45 462 800
2022-03-23 $24.65 $25.15 $23.80 $23.86 645 400
2022-03-22 $24.27 $25.00 $24.25 $24.96 599 629
2022-03-21 $25.53 $25.62 $24.06 $24.31 601 354
2022-03-18 $25.07 $25.97 $24.82 $25.56 1 798 020
2022-03-17 $24.17 $25.29 $23.63 $25.25 1 003 700
2022-03-16 $23.13 $24.19 $22.93 $24.17 877 800
2022-03-15 $22.26 $23.26 $22.11 $22.91 805 700
2022-03-14 $23.73 $24.17 $21.77 $22.22 1 598 500
2022-03-11 $25.00 $25.55 $23.70 $23.72 799 500

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and cancer in the United States. Its lead drug candidates in clinical development include CCX168, which is in Phase II clinical trials for the treatment of orphan and rare diseases; CCX872, which is in Phase I... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT